Cargando…

Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland

BACKGROUND: In Poland, the prevalence of cardiovascular diseases is increasing. This might be associated with the constantly growing proportion of elderly people and inappropriate cardiovascular prevention. This study aimed to evaluate the frequency of use of oral antiplatelet (OAP) and oral anticoa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labuz-Roszak, Beata, Pierzchala, Krystyna, Skrzypek, Michal, Swiech, Marta, Machowska-Majchrzak, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519729/ https://www.ncbi.nlm.nih.gov/pubmed/23114009 http://dx.doi.org/10.1186/1471-2261-12-98

Ejemplares similares

Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study)
por: Łabuz-Roszak, Beata, et al.
Publicado: (2017)

Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of stroke
por: Łabuz-Roszak, Beata, et al.
Publicado: (2015)

Sexual Satisfaction in Fully Ambulatory People with Multiple Sclerosis: Does Disability Matter?
por: Dobrakowski, Pawel, et al.
Publicado: (2020)

Association between electrocardiographic and electroencephalographic changes in patients with epilepsy
por: Mańka-Gaca, Iwona, et al.
Publicado: (2019)

Calcium–phosphate metabolism in patients with multiple sclerosis
por: Kubicka-Baczyk, K., et al.
Publicado: (2015)

Subarachnoid Haemorrhage—Incidence of Hospitalization, Management and Case Fatality Rate—In the Silesian Province, Poland, in the Years 2009–2019
por: Łabuz-Roszak, Beata, et al.
Publicado: (2022)

Assessment of Life Satisfaction of the Physicians of the Silesian Province, Poland
por: Niewiadomska, Ewa, et al.
Publicado: (2023)

Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking
por: Łabuz-Roszak, B., et al.
Publicado: (2014)

Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)

Postpandemic Stress Disorder among Health Care Personnel: A Cross-Sectional Study (Silesia, Poland)
por: Grajek, Mateusz, et al.
Publicado: (2022)

Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013)

Dual Anticoagulant/Antiplatelet Activity of Polyphenolic Grape Seeds Extract
por: Bijak, Michal, et al.
Publicado: (2019)

How does the risk of cardiovascular death and cardiovascular risk factor profiles differ between socioeconomic classes in Poland: A country in transition
por: Nadrowski, Pawel, et al.
Publicado: (2019)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
por: Damasiewicz-Bodzek, Aleksandra, et al.
Publicado: (2021)

Influence of Oral Anticoagulation and Antiplatelet Drugs on Outcome of Elderly Severely Injured Patients
por: Kerschbaum, Maximilian, et al.
Publicado: (2021)

Interactions between neurology and architecture – creating the built environment and its impact on the brain
por: Łabuz-Roszak, Beata, et al.
Publicado: (2018)

Anticoagulant Activities of Indobufen, an Antiplatelet Drug
por: Liu, Jia, et al.
Publicado: (2018)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Potentially inappropriate prescribing of cardiovascular system and antiplatelet/anticoagulant drugs among elderly patients: a Korean population-based national study
por: Kim, Jongyeon, et al.
Publicado: (2021)

Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes
por: Braczkowski, Michał, et al.
Publicado: (2023)

Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs
por: Hofmeier, Kathrin Scherer
Publicado: (2015)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

The Physical and Mental Well-Being of Medical Doctors in the Silesian Voivodeship
por: Niewiadomska, Ewa, et al.
Publicado: (2022)

Sleep disorders among educationally active elderly people in Bialystok, Poland: a cross-sectional study
por: Cybulski, Mateusz, et al.
Publicado: (2019)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

New aspects on efficient anticoagulation and antiplatelet strategies in sheep
por: Weigand, Annika, et al.
Publicado: (2013)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents
por: Zullo, Angelo, et al.
Publicado: (2017)

Antiplatelet and anticoagulation strategies for left ventricular assist devices
por: Loyaga-Rendon, Renzo Y., et al.
Publicado: (2021)

AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
por: Winzely, Maximilian, et al.
Publicado: (2021)

Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice
por: Aldhaeefi, Mohammed, et al.
Publicado: (2023)

Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
por: Confalonieri, Filippo, et al.
Publicado: (2023)

Clinical outcomes for patients on antiplatelet and anticoagulants in thoracoabdominal trauma
por: Sharp, Victoria, et al.
Publicado: (2023)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

The Ministry of Religious Congregations to People Affected by the SARS-CoV-2 Coronavirus in Poland: Geographies of Care During the COVID-19 Pandemic
por: Mróz, Franciszek, et al.
Publicado: (2022)

Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial
por: Bhatt, Deepak L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p3igvmjcmin138ufn3scv7t255